Tech Company Financing Transactions
SmartZyme Funding Round
On 10/28/2015, SmartZyme raised $4 million in financing from private investors and OrbiMed.
Transaction Overview
Company Name
Announced On
10/28/2015
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
private investors (Stephen Squinto)
OrbiMed (Nissim Darvish)
Proceeds Purpose
The investment by OrbiMed will allow us to continue developing new therapeutics using our Provolution protein technology and to improve the administration of existing biologics as we prepare to license our innovative enzyme and device for diabetic blood glucose monitoring.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
575 Lexington Ave.
New York, NY 10022
USA
New York, NY 10022
USA
Phone
Website
Email Address
Not Recorded
Overview
SmartZyme Innovation is a Life Science company using a proprietary technological platform for protein design and engineering in accordance with industry required specifications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shilo Ben-Zeev
Chief Financial Officer
Motty Hershkowitz
Chief Operating Officer
Eyal Sandach
Chief Technical Officer
David Baram
Browse more venture capital transactions:
Prev: 10/28/2015: Zype venture capital transaction
Next: 10/28/2015: Sportradar venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs